Keyphrases
Acute Myeloid Leukemia
100%
B Cells
10%
Beta Chain
20%
Biological Correlation
10%
CD10
10%
CD14
10%
CD19
10%
CD34
10%
Cytochemistry
10%
Cytogenetic Abnormalities
10%
Early Antigen
10%
Eastern Cooperative Oncology Group
10%
Gene Rearrangement
20%
Genotypic Correlation
100%
Group Treatment
10%
HLA-DR
10%
Immunoglobulin
20%
Immunoglobulin Gene Rearrangement
10%
Immunoglobulin Light Chains
10%
Immunoglobulin Loci
10%
Immunophenotypic Profile
20%
Inv(16)
10%
Leukemia Patients
20%
Low Incidence
10%
Myelomonocytic
10%
Normal Karyotype
10%
Nuclear Reactivity
10%
Phenotypic Correlation
100%
Protein Analysis
10%
Ribonuclease Protection Assay
10%
RNA Analysis
10%
T Cells
20%
Treatment Protocol
10%
Medicine and Dentistry
Absence
10%
Acute Myeloid Leukemia
100%
Beta Chain
20%
CD19 Antigen
10%
CD34 Antigen
10%
Cytochemistry
10%
Early Antigen
10%
Gene Rearrangement
30%
Group Therapy
10%
Immunoglobulin
30%
Immunoglobulin Gene
10%
Immunoglobulin Light Chain
10%
Karyotype
20%
Oncology
10%
Protein Analysis
10%
Receptor
20%
Ribonuclease Protection Assay
10%
RNA Analysis
10%
Biochemistry, Genetics and Molecular Biology
Beta Chain
20%
CD14
10%
CD19
10%
CD34
10%
Cytochemistry
10%
Cytogenetics
10%
Eicosanoid Receptor
20%
Gene Rearrangement
30%
Immunoglobulin Gene
10%
Intravenous Immunoglobulin
40%
Karyotype
20%
Light Chain
10%
Myeloid
100%
Ribonuclease
10%
RNA
10%
Immunology and Microbiology
Beta Chain
20%
CD14
10%
CD19 Antigen
10%
CD34 Antigen
10%
Early Antigen
10%
Gene Rearrangement
30%
Immunoglobulin Gene
10%
Immunoglobulin Light Chain
10%
Intravenous Immunoglobulin
30%
Karyotype
20%
Myeloid
100%